作者
Shefali S. Verma,Harini V. Gudiseva,Venkata Ramana Murthy Chavali,Rebecca Salowe,Yuki Bradford,Lindsay Guare,Anastasia Lucas,David W. Collins,Vrathasha Vrathasha,Rohini Nair,Sonika Rathi,Bingxin Zhao,Jie He,Roy Lee,Selam Zenebe-Gete,Anita S. Bowman,Caitlin McHugh,Michael C. Zody,Maxwell Pistilli,Naira Khachatryan,Ebenezer Daniel,Windell Murphy,Jeffrey Henderer,Tyler G. Kinzy,Sudha K. Iyengar,Neal S. Peachey,Kent D. Taylor,Xiuqing Guo,Yii‐Der Ida Chen,Linda M. Zangwill,Christopher A. Girkin,Radha Ayyagari,Jeffrey M. Liebmann,Chimd M. Chuka-Okosa,Susan Williams,Stephen Akafo,Donald L. Budenz,Olusola Olawoye,Michèle Ramsay,Adeyinka Ashaye,Onoja Akpa,Tin Aung,Janey L. Wiggs,Ahmara G. Ross,Qi N. Cui,Victoria Addis,Amanda Lehman,Eydie Miller-Ellis,Prithvi S. Sankar,Scott M. Williams,Gui‐Shuang Ying,Jessica N. Cooke Bailey,Jerome I. Rotter,Robert N. Weinreb,Chiea Chuen Khor,Michael A. Hauser,Marylyn D. Ritchie,Joan M. O’Brien
摘要
Primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, disproportionately affects individuals of African ancestry. We conducted a genome-wide association study (GWAS) for POAG in 11,275 individuals of African ancestry (6,003 cases; 5,272 controls). We detected 46 risk loci associated with POAG at genome-wide significance. Replication and post-GWAS analyses, including functionally informed fine-mapping, multiple trait co-localization, and in silico validation, implicated two previously undescribed variants (rs1666698 mapping to DBF4P2; rs34957764 mapping to ROCK1P1) and one previously associated variant (rs11824032 mapping to ARHGEF12) as likely causal. For individuals of African ancestry, a polygenic risk score (PRS) for POAG from our mega-analysis (African ancestry individuals) outperformed a PRS from summary statistics of a much larger GWAS derived from European ancestry individuals. This study quantifies the genetic architecture similarities and differences between African and non-African ancestry populations for this blinding disease.